BRPI0923191A2 - metodos relacionados com glicanos modificados - Google Patents

metodos relacionados com glicanos modificados

Info

Publication number
BRPI0923191A2
BRPI0923191A2 BRPI0923191A BRPI0923191A BRPI0923191A2 BR PI0923191 A2 BRPI0923191 A2 BR PI0923191A2 BR PI0923191 A BRPI0923191 A BR PI0923191A BR PI0923191 A BRPI0923191 A BR PI0923191A BR PI0923191 A2 BRPI0923191 A2 BR PI0923191A2
Authority
BR
Brazil
Prior art keywords
related methods
modified glycan
glycan related
modified
methods
Prior art date
Application number
BRPI0923191A
Other languages
English (en)
Inventor
Carlos J Bosques
Cuihua Liu
Jennifer Lynn Murphy
Sibel Nur Gunay
Zachary Shriver
Original Assignee
Momenta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc
Publication of BRPI0923191A2 publication Critical patent/BRPI0923191A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
BRPI0923191A 2008-12-19 2009-12-18 metodos relacionados com glicanos modificados BRPI0923191A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13922408P 2008-12-19 2008-12-19
PCT/US2009/068790 WO2010071824A2 (en) 2008-12-19 2009-12-18 Methods related to modified glycans

Publications (1)

Publication Number Publication Date
BRPI0923191A2 true BRPI0923191A2 (pt) 2016-02-16

Family

ID=42269281

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923191A BRPI0923191A2 (pt) 2008-12-19 2009-12-18 metodos relacionados com glicanos modificados

Country Status (9)

Country Link
US (1) US9103821B2 (pt)
EP (1) EP2358731B1 (pt)
JP (1) JP2012513030A (pt)
CN (1) CN102239173A (pt)
AU (1) AU2009327435A1 (pt)
BR (1) BRPI0923191A2 (pt)
CA (1) CA2743181A1 (pt)
RU (1) RU2526250C2 (pt)
WO (1) WO2010071824A2 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2012162160A1 (en) * 2011-05-20 2012-11-29 Momenta Pharmaceuticals, Inc. Modified glycoproteins
CN102584728B (zh) * 2011-12-16 2014-06-04 北京大学 一类基于三嗪结构的糖标记试剂及其合成方法和应用
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US20150210753A1 (en) 2012-07-26 2015-07-30 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
WO2014179601A2 (en) 2013-05-02 2014-11-06 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
GB201320571D0 (en) * 2013-11-21 2014-01-08 Academisch Ziekenhuis Leiden Glycan analysis
CN104677971B (zh) * 2013-11-26 2017-12-26 杭州九源基因工程有限公司 一种epo突变体的毛细管电泳检测方法
CN104807927B (zh) * 2014-01-24 2016-08-17 中国医学科学院基础医学研究所 一种富集唾液酸化糖肽的方法
ES2727380T3 (es) * 2014-11-19 2019-10-15 Amgen Inc Cuantificación de resto glucano en glucoproteínas recombinantes
CA2977271A1 (en) 2015-03-02 2016-09-09 Synthetic Genomics, Inc. Regulatory elements from labyrinthulomycetes microorganisms
WO2017117218A1 (en) 2015-12-30 2017-07-06 Momenta Pharmaceuticals, Inc. Methods related to biologics
US10633454B2 (en) 2016-11-01 2020-04-28 Conagen Inc. Expression of modified glycoproteins and glycopeptides
EP3762485A4 (en) * 2018-03-05 2021-12-08 Conagen Inc. ORGANISMS AND METHOD FOR MANUFACTURING GLYCOMOLECULES WITH LOW SULFATION
CN108459116B (zh) * 2018-07-06 2021-02-19 贵州大学 一种荧光高效液相色谱检测发酵红肉制品中Neu5Gc的方法
CN113438953A (zh) 2018-10-11 2021-09-24 动量制药公司 采用高度唾液酸化IgG组合物的治疗
CA3125443A1 (en) 2018-12-31 2020-07-09 Momenta Pharmaceuticals, Inc. Methods of producing ustekinumab

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE19527054A1 (de) * 1995-07-26 1997-01-30 Behringwerke Ag Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
AU2001276842B2 (en) 2000-06-28 2007-04-26 Glycofi, Inc. Methods for producing modified glycoproteins
US20060127950A1 (en) * 2004-04-15 2006-06-15 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
WO2007047687A2 (en) 2005-10-14 2007-04-26 Zymequest, Inc. Compositions and methods for prolonging survival of platelets
US8039208B2 (en) * 2005-04-26 2011-10-18 National Institute For Bioprocessing Research And Training Limited (Nibrt) Automated strategy for identifying physiological glycosylation markers(s)
FI20055398A0 (fi) * 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
US8440191B2 (en) 2005-11-18 2013-05-14 Tufts Medical Center Clearance of abnormal IGA1 in IGA1 deposition diseases
AU2007254777B2 (en) 2006-06-02 2014-02-20 Robert Sackstein Compositions and methods for modifying cell surface glycans
AU2008243007A1 (en) 2007-04-16 2008-10-30 Momenta Pharmaceuticals, Inc. Characterization of N-glycans using exoglycosidases
CA2682744C (en) * 2007-04-16 2015-10-06 Momenta Pharmaceuticals, Inc. Methods related to cell surface glyosylation

Also Published As

Publication number Publication date
RU2526250C2 (ru) 2014-08-20
EP2358731A2 (en) 2011-08-24
RU2011129747A (ru) 2013-01-27
EP2358731B1 (en) 2016-03-09
WO2010071824A2 (en) 2010-06-24
AU2009327435A1 (en) 2010-06-24
US20110306075A1 (en) 2011-12-15
US9103821B2 (en) 2015-08-11
JP2012513030A (ja) 2012-06-07
EP2358731A4 (en) 2012-08-08
WO2010071824A3 (en) 2010-10-28
CA2743181A1 (en) 2010-06-24
CN102239173A (zh) 2011-11-09

Similar Documents

Publication Publication Date Title
BRPI0923191A2 (pt) metodos relacionados com glicanos modificados
PT2813570T (pt) Resumo
EP3988147C0 (en) INSERT SET
DE602009000234D1 (de) msignals
BRPI0907376A2 (pt) Fotobiorretador
EP2258938A4 (en) TYPE VEHICLE TO BE PROVIDED
DK3444343T3 (da) Polypeptider
PT3045471T (pt) Resumo
BRPI0914649A2 (pt) Piprazolo-quinazolinas
EP2336764A4 (en) LIQUID CHROMATOGRAPH
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
EP2320913A4 (en) NUCLEIC ACID APTAMERS
DK2342454T3 (da) Vindkraftanlæg
DK2336132T3 (da) Morpholinpurinderivat
EP2368115A4 (en) ANALYTE DETECTION TEST
EP2308156A4 (en) STEP ACTUATOR
DK2379557T3 (da) Aminopyrazol-forbindelse
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
DE602008003970D1 (de) Strahlstromkalibriersystem
BRPI0911625A2 (pt) Métodos
EP2257170A4 (en) TETRAHYDROFUROPYRIDONE
EP2248964A4 (en) DRILLING / TERMINAL DEVICE
EP2360457A4 (en) Gas shutoff device
DE112009000183A5 (de) Sicherheitsvorreiber
EP2339366A4 (en) DEVICE FOR OPTICAL DISTANCE MEASUREMENT

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa)

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal
B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL